Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells
The synergistic effect of combined drug therapy provides an enhanced treatment for advanced liver cancer. We aimed to investigate the underlying mechanism of cetuximab sensitization by rapamycin in hepatoma cells. Four hepatoma cell lines, HepG2, HuH7, SNU-387, and SNU-449, were treated with cetuxim...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Landes Bioscience
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4119084/ https://ncbi.nlm.nih.gov/pubmed/24800850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.29113 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
載入...